Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Rosalba Poggi"'
Autor:
Maria Vitiello, Giuseppe Plazzi, Elena Antelmi, Emanuela Postiglione, Fabio Pizza, Rocco Liguori, Rosalba Poggi
Publikováno v:
Sleep Medicine. 52:23-25
n.a.
Autor:
Carmelo Lucio Sturiale, Maurizio Mascarin, Damiano Balestrini, Barbara Masotto, Enrico Franceschi, Rosalba Poggi, Lorenzo Volpin, Gianluca Marucci, Daniela Danieli, Alexandro Paccapelo, Aa Brandes, Marina Paola Gardiman, Marco Bartolotti, Raffaele Agati, Claudio Ghimenton
Publikováno v:
Europe PubMed Central
The standard treatment in children with average-risk medulloblastoma (MB) is reduced-dose radiotherapy (RT) followed by chemotherapy. However, in adults, there is no agreement on the use of adjuvant chemotherapy. We performed a retrospective analysis
Publikováno v:
Current Treatment Options in Oncology. 17
At the time of glioblastoma (GBM) recurrence, a sharp analysis of prognostic factors, disease characteristics, response to adjuvant treatment, and clinical conditions should be performed. A prognostic assessment could allow a careful selection betwee
Autor:
Lorenzo Volpin, Stefania Bartolini, Mario Ermani, Mino Zucchelli, Andrea Talacchi, Marco Bartolotti, Gianluca Marucci, Antonella Bacci, C Bortolotti, Stefano Pizzolitto, Enrico Franceschi, Alicia Tosoni, Rosalba Poggi, Renato Galzio, Alba A. Brandes, Claudio Ghimenton, Daniela Danieli, Annalisa Pession, Alexandro Paccapelo, Dario de Biase
Background: The most appropriate management of recurrent glioblastoma is still controversial. In particular, the role of surgery at recurrence remains uncertain. Patients & methods: From our Institutional data warehouse we analyzed 270 consecutive pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c3bb93322837f3bbeca5985dac9b76b
http://hdl.handle.net/11585/590879
http://hdl.handle.net/11585/590879
Bevacizumab, currently an option for treatment of different types of tumors including glioblastoma, has a peculiar toxicity profile related to its antiangiogenic effect. Because some bevacizumab-related adverse events can be life threatening, it is i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d29a3906eaa82a201ff48f5ad097c1f
https://europepmc.org/articles/PMC4319633/
https://europepmc.org/articles/PMC4319633/
Autor:
Giovanna Cavallo, Federica Marzocchi Avventuroso, Cinzia Susini, Rosalba Poggi, Laura Lombardo, Monica Di Battista, Paolo Pandolfi, Rina Renzi, Alba A. Brandes, Margherita Galli, Enrico Franceschi, Roberta Degli Esposti, Natalina Collina, Muriel Assunta Musti, Giovanni Frezza, Simonetta Rimondini, Gioacchino Pagliaro, Linda Marconi, Sara De Lisio
Publikováno v:
Explore (New York, N.Y.). 12(1)
Context Tong Len meditation is an important therapeutic tool in the Tibetan medicine, and it can be used for self-healing and/or to heal others. Currently, in the West, there is no scientific study concerning the efficacy of a Tong Len distant healin
Autor:
Alicia Tosoni, Alba A. Brandes, Marco Bartolotti, Enrico Franceschi, Rosalba Poggi, Monica Di Battista
Publikováno v:
Future oncology (London, England). 10(8)
ABSTRACT: Angiogenesis is a key process for tumoral growth, which has become a main target for anticancer treatments. A wide number of agents targeting both VEGF and its receptor have recently become standard treatments for different tumor types. Unf
Autor:
Damiano Balestrini, Raffaele Agati, Marco Bartolotti, Gianluca Marucci, Mario Ermani, Stefania Bartolini, Alicia Tosoni, Eugenio Pozzati, Enrico Franceschi, Giovanni Tallini, Claudio Ghimenton, Luca Morandi, Rosalba Poggi, Alba A. Brandes, Antonella Bacci, Girolamo Crisi, A. Fioravanti
Publikováno v:
Journal of neuro-oncology. 121(2)
The optimal end point for phase II studies for recurrent glioblastoma (GBM) is unclear and a matter of debate. Moreover, data about post-progression survival (PPS) after the first disease progression in GBM patients treated according to EORTC 26981/2
Autor:
Dario Palleschi, Monica Di Battista, Marco Bartolotti, Alba A. Brandes, Rosalba Poggi, Enrico Franceschi
Publikováno v:
Expert review of anticancer therapy. 14(1)
For many years, brain metastases (BMs) have been considered as the final stage of a disease course and engendered skepticism about the efficacy of treatments. Local treatments, mainly, whole-brain radiotherapy have been the standard of care, whereas
Autor:
Gianluca Marucci, Antonella Mura, Dario de Biase, Lorenzo Volpin, Andrea Pession, Alicia Tosoni, L. Albini Riccioli, Enrico Franceschi, Michele Reni, C. Degli Esposti, Aa Brandes, Alexandro Paccapelo, Giovenzio Genestreti, Daniela Danieli, Stefania Bartolini, C Bortolotti, Giovanni Tallini, Claudio Ghimenton, Luigi Cirillo, Rosalba Poggi
Publikováno v:
Annals of Oncology. 27:vi103